Skin Cancer Clinical Negligence Claims: A Practical Guide to Delay and Causation

A lesion is missed, diagnosis is delayed and the patient later requires more extensive treatment or develops metastatic disease. However, a poor clinical pathway does not automatically amount to a strong negligence claim.

For solicitors, the central question is not simply whether there was a delay. It is whether earlier diagnosis would probably have changed the treatment, prognosis or eventual outcome. Without that causative link, even an obvious breach may not result in a viable claim.

The behaviour of the particular cancer also matters. A delay that is largely irrelevant in a slow-growing basal cell carcinoma may be critical in melanoma or an aggressive squamous cell carcinoma. Misunderstanding those differences can lead to the claim being overstated, undervalued or built around the wrong expert evidence.

Download The Guide Here >

Drawing on his experience as a Consultant Oncologist, Dr Stephen Falk shares practical insights from his recent INNEG webinar, Skin Cancer Clinical Negligence Claims.

Rather than offering a general overview of skin cancer, this guide focuses on the clinical and evidential issues that determine whether delayed diagnosis claims succeed or fail.

Inside you’ll discover:

• Why breach and causation must be assessed separately.
• What contemporaneous records, lesion descriptions and photographs may reveal about the original assessment.
• Why a missed follow-up does not necessarily mean that later metastasis was avoidable.
• How basal cell carcinoma, squamous cell carcinoma and melanoma create different causation and valuation issues.
• Why local consequences such as scarring, reconstruction and functional loss may be more important than oncology arguments in some claims.
• How occult disease and microscopic spread can undermine an apparently strong delay case.
• Why modern immunotherapy may fundamentally alter prognosis and the value of a melanoma claim.
• How lead time bias can make earlier diagnosis appear more beneficial than it would actually have been.
• The questions expert evidence must answer before a skin cancer claim is pleaded, valued or settled.

Whether you are assessing breach, investigating causation or preparing instructions for an oncology expert, this guide will help you identify where the genuine strength or weakness of a skin cancer claim lies. It is designed to help solicitors test the evidence earlier, avoid weak assumptions and frame allegations around the consequences the delay probably caused.

Download your free copy today.